Ratika Kunder

439 total citations
5 papers, 330 citations indexed

About

Ratika Kunder is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Ratika Kunder has authored 5 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Ratika Kunder's work include MicroRNA in disease regulation (3 papers), Circular RNAs in diseases (3 papers) and Cancer-related molecular mechanisms research (2 papers). Ratika Kunder is often cited by papers focused on MicroRNA in disease regulation (3 papers), Circular RNAs in diseases (3 papers) and Cancer-related molecular mechanisms research (2 papers). Ratika Kunder collaborates with scholars based in India, United States and Philippines. Ratika Kunder's co-authors include Neelam Shirsat, Atul Goel, Aliasgar Moiyadi, Sadhana Kannan, Rajiv Sarin, Asha Shenoy, Santosh Noronha, Dai Horiuchi, Paul Yaswen and Michael T. McManus and has published in prestigious journals such as Nature Medicine, Neuro-Oncology and Acta Neuropathologica Communications.

In The Last Decade

Ratika Kunder

5 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ratika Kunder India	5	256	145	83	73	49	5	330
Andres Forero Colombia	6	153 0.6×	62 0.4×	61 0.7×	79 1.1×	21 0.4×	14	305
M. Nieves Calvo-Vidal United States	7	143 0.6×	70 0.5×	96 1.2×	148 2.0×	61 1.2×	7	290
Melissa Q. McCreery United States	6	181 0.7×	71 0.5×	21 0.3×	85 1.2×	78 1.6×	9	370
Sherona Sirkisoon United States	10	286 1.1×	109 0.8×	48 0.6×	193 2.6×	54 1.1×	16	439
Suyun Huang United States	6	293 1.1×	80 0.6×	30 0.4×	99 1.4×	22 0.4×	7	362
Anagha Deshpande United States	11	429 1.7×	75 0.5×	41 0.5×	123 1.7×	83 1.7×	26	579
Verónica Moncho-Amor Spain	8	263 1.0×	128 0.9×	17 0.2×	96 1.3×	40 0.8×	15	366
Giulia Cheloni United States	10	316 1.2×	173 1.2×	16 0.2×	63 0.9×	85 1.7×	22	483
Zhijian Yue China	12	263 1.0×	200 1.4×	21 0.3×	70 1.0×	39 0.8×	20	383
Lyndsey Hanson United Kingdom	7	204 0.8×	54 0.4×	31 0.4×	85 1.2×	16 0.3×	11	290

Countries citing papers authored by Ratika Kunder

Since Specialization

Citations

This map shows the geographic impact of Ratika Kunder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ratika Kunder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ratika Kunder more than expected).

Fields of papers citing papers by Ratika Kunder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ratika Kunder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ratika Kunder. The network helps show where Ratika Kunder may publish in the future.

Co-authorship network of co-authors of Ratika Kunder

This figure shows the co-authorship network connecting the top 25 collaborators of Ratika Kunder. A scholar is included among the top collaborators of Ratika Kunder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ratika Kunder. Ratika Kunder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Kunder, Ratika, Sara F. Dunne, Byoung-Kyu Cho, et al.. (2021). Synergistic PIM kinase and proteasome inhibition as a therapeutic strategy for MYC-overexpressing triple-negative breast cancer. Cell chemical biology. 29(3). 358–372.e5. 14 indexed citations

2.

Panwalkar, Pooja, Rakesh Jalali, Sridhar Epari, et al.. (2019). Downregulation of miR-204 expression defines a highly aggressive subset of Group 3/Group 4 medulloblastomas. Acta Neuropathologica Communications. 7(1). 52–52. 21 indexed citations

3.

Horiuchi, Dai, Roman Camarda, Alicia Y. Zhou, et al.. (2016). PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression. Nature Medicine. 22(11). 1321–1329. 122 indexed citations

4.

Kunder, Ratika, Rakesh Jalali, Sridhar Epari, et al.. (2013). Real-time PCR assay based on the differential expression of microRNAs and protein-coding genes for molecular classification of formalin-fixed paraffin embedded medulloblastomas. Neuro-Oncology. 15(12). 1644–1651. 69 indexed citations

5.

Shirsat, Neelam, Ratika Kunder, Atul Goel, et al.. (2010). Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway. Journal of Cancer Research and Therapeutics. 6(4). 521–521. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact